3% Hypertonic Saline
3% Hypertonic Saline is a pharmaceutical drug with 11 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 9 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
1
Mid Stage
2
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
9 of 9 finished
0.0%
0 ended early
0
trials recruiting
11
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Comparison of 5% Hypertonic Saline Versus 3% Hypertonic Saline in Resolution of Post-operative Corneal Edema.
Phase I Assessment of Hypertonic Saline in Moderate to Severe Asthmatics
Comparison of 3% Hypertonic Saline and Salbutamol in Children With Bronchiolitis
Effect of Fluid Resuscitation on Lactate in Traumatic Injury Patients
Efficacy and Safety of Rapid Intermittent Compared With Slow Continuous Correction in Severe Hyponatremia Patients
Clinical Trials (11)
Comparison of 5% Hypertonic Saline Versus 3% Hypertonic Saline in Resolution of Post-operative Corneal Edema.
Phase I Assessment of Hypertonic Saline in Moderate to Severe Asthmatics
Comparison of 3% Hypertonic Saline and Salbutamol in Children With Bronchiolitis
Effect of Fluid Resuscitation on Lactate in Traumatic Injury Patients
Efficacy and Safety of Rapid Intermittent Compared With Slow Continuous Correction in Severe Hyponatremia Patients
Nebulized 3% Hypertonic Saline in the Treatment of Acute Bronchiolitis
Role of Hypertonic Saline Versus Mannitol in the Management of Raised Intracranial Pressure in Patients With ALF
The SABRE Trial of Hypertonic Saline in Acute Bronchiolitis
Nebulized Hypertonic Saline Treatment in Hospitalized Children With Moderate to Severe Viral Bronchiolitis
Use of Salt-Water Solution to Improve Symptoms in Concussion
The Use of an Inhaled Salt Solution to Treat Viral Lung Infections in Infants.
All 11 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 11